TipRanks
Amplia Therapeutics Ltd. (INNMF)
OTHER OTC:INNMF
US Market

Amplia Therapeutics (INNMF) Income Statement

19 Followers

Amplia Therapeutics Income Statement

Last quarter (Q4 2026), Amplia Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Amplia Therapeutics's net income was AU$-3.53M. See Amplia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
AU$ 0.00AU$ 3.78MAU$ 4.45MAU$ 1.19MAU$ 1.98M
Gross Profit
AU$ -92.14KAU$ 3.57MAU$ 4.01MAU$ 1.12MAU$ 1.98M
Operating Expenses
AU$ 13.09MAU$ 10.09MAU$ 8.44MAU$ 7.40MAU$ 5.62M
Depreciation and Amortization
AU$ 92.14KAU$ 9.96KAU$ 86.15KAU$ 73.37KAU$ 3.21K
EBITDA
AU$ -13.09MAU$ -6.78MAU$ -4.48MAU$ -7.26MAU$ -3.64M
Operating Income
AU$ -13.18MAU$ -6.52MAU$ -4.42MAU$ -7.48MAU$ -3.64M
Other Income/Expenses
AU$ 694.73KAU$ -55.88KAU$ -4.52MAU$ 84.46KAU$ -1.15K
Pretax Income
AU$ -12.49MAU$ -6.57MAU$ -8.94MAU$ -7.39MAU$ -3.64M
Net Income
AU$ -7.71MAU$ -6.57MAU$ -4.50MAU$ -6.24MAU$ -3.64M
Per Share Metrics
Basic EPS
AU$ -0.02AU$ -0.02AU$ -0.02AU$ -0.03AU$ -0.03
Diluted EPS
AU$ -0.02AU$ -0.02AU$ -0.02AU$ -0.03AU$ -0.03
Weighted Average Shares Outstanding
469.65M 307.10M 194.01M 193.98M 145.55M
Weighted Average Shares Outstanding (Diluted)
469.65M 307.21M 194.01M 193.98M 145.55M
Currency in AUD

Amplia Therapeutics Earnings and Revenue History